Herbalife financials
$12.44−1.27%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.05B | $5.01B | $5.07B | $5.21B | $5.80B | $5.54B | $4.88B | $4.91B | $4.44B | $4.49B |
| Gross profit | $3.93B | $3.90B | $3.88B | $4.04B | $4.56B | $4.39B | $3.92B | $3.99B | $3.59B | $3.64B |
| Gross margin | 77.9% | 77.9% | 76.5% | 77.5% | 78.6% | 79.2% | 80.4% | 81.3% | 80.9% | 81.0% |
| Operating income | $484.7M | $392.7M | $357.7M | $551.3M | $734.1M | $640.6M | $568.1M | $702.5M | $631.6M | $464.0M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M | $372.6M | $311.0M | $296.6M | $213.9M | $260.0M |
| Net margin | 4.5% | 5.1% | 2.8% | 6.2% | 7.7% | 6.7% | 6.4% | 6.0% | 4.8% | 5.8% |
| Diluted EPS | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $2.77 | $2.20 | $1.98 | $1.29 | $1.51 |
| EBITDA | $605.9M | $514.1M | $471.0M | $666.7M | $841.7M | $740.9M | $665.8M | $802.9M | $731.4M | $562.3M |
| Operating cash flow | $333.3M | $285.4M | $357.5M | $352.5M | $460.3M | $628.6M | $457.5M | $648.4M | $590.8M | $367.3M |
| Free cash flow | $252.9M | $163.4M | $222.5M | $196.1M | $308.9M | $516.6M | $351.4M | $564.4M | $495.3M | $223.9M |
| Diluted shares | 103.6M | 101.6M | 100.2M | 99.5M | 108.3M | 134.5M | 141.6M | 149.5M | 165.7M | 172.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $353.1M | $415.3M | $575.2M | $508.0M | $601.5M | $1.05B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $1.99B | $2.26B | $2.91B | $2.69B | $2.76B | $2.43B |
| Total assets | $2.79B | $2.73B | $2.81B | $2.73B | $2.82B | $3.08B |
| Total liabilities | $3.30B | $3.53B | $3.87B | $4.00B | $4.21B | $3.93B |
| Shareholders' equity | -$509.4M | -$801.1M | -$1.06B | -$1.27B | -$1.39B | -$856.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology